Alabama 2025 Regular Session

Alabama Senate Bill SB93

Introduced
2/4/25  

Caption

Pharmacy Benefits Managers; providing additional regulation of practices

Companion Bills

No companion bills found.

Previously Filed As

AL HB238

Pharmacy Benefits Managers; Providing more regulation

AL HB52

Board of Pharmacy, compounding pharmacies, number of pharmacy techs reg by board rule

AL SB15

Board of Pharmacy, compounding pharmacies, number of pharmacy technicians regulated by board rule

AL HB460

Occupational and professional licensing boards, prohibited from purchasing or acquiring real property commencing on October 1, 2024

AL HB390

Alabama Medical Cannabis Commission; primary responsibility over regulation, licensing, and enforcement of cannabis cultivation authorized

AL SB313

Prohibit "balance billing" by ground ambulances

AL HB401

Prohibit "balance billing" by ground ambulances

AL SB259

Mixed Spirit Beverages; providing for definition, licensure, and distribution

AL SB293

Tort Reform, to regulate litigation financing agreements, vicarious liability of employers, proof of medical care expenses, and attorney advertising

AL HB420

Tort Reform, to regulate litigation financing agreements, vicarious liability of employers, proof of medical care expenses, and attorney advertising

Similar Bills

AL SB252

Pharmacy Benefits Managers; providing a prescription reimbursement rate for independent pharmacies and regulating other practices

AL HB238

Pharmacy Benefits Managers; Providing more regulation

AL SB99

Drug Insurance Benefits; impose more restrictions on pharmacy benefit managers

WV HB4112

Provide consumers a choice for pharmacy services

IL HB3761

INS-PBM/DUTIES & PROHIBITIONS

NH HB1580

Relative to pharmacy benefits managers.

WI AB173

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

WI SB203

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)